Award recordCONTRACT

ALBA BIOSCIENCE, INC.

PIID 36C25524N0268· VHA· 255-NETWORK CONTRACT OFFICE 15 (36C255)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2024· $34,932 net obligations· UEI V6KNKL6BDHL7· PA

Description

CORRECT FUNDING/BLOOD BANK REAGENTS. DE-OB MODIFICATION OF $1,779.99 ON PO#: 589C40149.

Base award description: BLOOD BANK REAGENTS OY3

First action · last action
2024-05-14 · 2026-03-26
Transactions
10
First transaction's obligation
$48,097
Base + all options value (sum of deltas)
$34,932
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25520A0034
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 10 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$48,933$0Base award · 2024-05-14 · this action $48,097 · running total $48,097Modification P00001 · 2025-03-07 · this action $229 · running total $48,326Modification P00002 · 2025-05-05 · this action $607 · running total $48,933Modification P00003 · 2025-08-21 · this action -$4,415 · running total $44,518Modification P00004 · 2025-09-18 · this action -$580 · running total $43,938Modification P00005 · 2025-09-30 · this action -$3,272 · running total $40,666Modification P00006 · 2025-09-30 · this action -$2,982 · running total $37,685Modification P00007 · 2026-02-27 · this action -$575 · running total $37,109Modification P00008 · 2026-03-26 · this action -$398 · running total $36,712Modification P00009 · 2026-03-26 · this action -$1,780 · running total $34,932
  • Base2024-05-14+$48,097= $48,097
  • Mod P000012025-03-07+$229= $48,326
  • Mod P000022025-05-05+$607= $48,933
  • Mod P000032025-08-21-$4,415= $44,518
  • Mod P000042025-09-18-$580= $43,938
  • Mod P000052025-09-30-$3,272= $40,666
  • Mod P000062025-09-30-$2,982= $37,685
  • Mod P000072026-02-27-$575= $37,109
  • Mod P000082026-03-26-$398= $36,712
  • Mod P000092026-03-26-$1,780= $34,932
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-05-14+$48,097$48,097BLOOD BANK REAGENTS OY3
Mod P00001· FUNDING ONLY ACTION2025-03-07+$229$48,326CORRECT FUNDING/BLOOD BANK REAGENTS OY3
Mod P00002· FUNDING ONLY ACTION2025-05-05+$607$48,933CORRECT FUNDING/BLOOD BANK REAGENTS OY3
Mod P00003· FUNDING ONLY ACTION2025-08-21−$4,415$44,518CORRECT FUNDING/BLOOD BANK REAGENTS OY3
Mod P00004· FUNDING ONLY ACTION2025-09-18−$580$43,938CORRECT FUNDING/BLOOD BANK REAGENTS OY3
Mod P00005· FUNDING ONLY ACTION2025-09-30−$3,272$40,666CORRECT FUNDING/BLOOD BANK REAGENTS OY3
Mod P00006· FUNDING ONLY ACTION2025-09-30−$2,982$37,685CORRECT FUNDING/BLOOD BANK REAGENTS OY3
Mod P00007· OTHER ADMINISTRATIVE ACTION2026-02-27−$575$37,109CORRECT FUNDING/BLOOD BANK REAGENTS. DE-OB MODIFICATION.
Mod P00008· FUNDING ONLY ACTION2026-03-26−$398$36,712CORRECT FUNDING/BLOOD BANK REAGENTS. DE-OB MODIFICATION OF $397.58 ON PO#: 589C43147.
Mod P00009· FUNDING ONLY ACTION2026-03-26−$1,780$34,932CORRECT FUNDING/BLOOD BANK REAGENTS. DE-OB MODIFICATION OF $1,779.99 ON PO#: 589C40149.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI V6KNKL6BDHL7)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0306255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$40,949FY2026
36C25926N0280NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$64,078FY2026
36C25726N0176257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$7,634FY2026
36C25726N0224257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$16,514FY2026
36C25626N0214256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$23,127FY2026
36C25026N0043250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$21,884FY2026

Other recipients under 6550 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25526N0405FISHER SCIENTIFIC COMPANY L.L.C.255-NETWORK CONTRACT OFFICE 15 (36C255)$113,611FY2026
36C25526N0337CEPHEID255-NETWORK CONTRACT OFFICE 15 (36C255)$2,571,141FY2026
36C25526N0307WERFEN USA LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$76,810FY2026
36C25526N0312QUIDELORTHO SALES COMPANY, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$21,363FY2026
36C25526A0030QUIDELORTHO SALES COMPANY, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25524N0268_3600_36C25520A0034_3600 · retrieved 2026-09-26.